Pure Global

Rapid test for detection of SARS-CoV-2 Antigen in human nasal swab and nasopharyngeal swab specimens(PerkinElmer COVID-19 Antigen Test ) - India CDSCO Medical Device Registration

Rapid test for detection of SARS-CoV-2 Antigen in human nasal swab and nasopharyngeal swab specimens(PerkinElmer COVID-19 Antigen Test ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000043_9c6cdc17acf46c3d4aae143541ef05e1_e204164e8ec507e27af345e632fa0498. This device is marketed under the brand name CA 15-3. The license holder is ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Sub Zonal Goa.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Rapid test for detection of SARS-CoV-2 Antigen in human nasal swab and nasopharyngeal swab specimens(PerkinElmer COVID-19 Antigen Test )
UID: MFG/IVD/2020/000043_9c6cdc17acf46c3d4aae143541ef05e1_e204164e8ec507e27af345e632fa0498

Brand Name

CA 15-3

Device Class

Class C

Approving Authority

Sub Zonal Goa

Product Information

PerkinElmer COVID-19 Antigen Test (CA 15-3) is an invitro, rapid, qualitative immunoassay for the detection of specific antigens expressed by the SARS-CoV-2 virus present in human nasopharyngeal swab and nasal swab specimens. It is to be used for screening or to aid in the diagnosis of COVID-19 disease and exposure to the virus. This rapid antigen detection test takes 20-30 minutes for producing a positive or negative test result. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or other management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The result of this test should not be the sole basis for the diagnosis. Presumptive positive or negative result with the Rapid Antigen. Test may need to be further confirmed with a molecular test, as needed

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (10)
Other products with the same name or brand

Rapid Test for Malaria Pv/Pf

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Rapid Test for Malaria PAN/Pf

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Rapid Test for Malaria PAN

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Rapid Test for Syphilis (SYPHICHECK )

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Enzyme Linked Immunosorbent Assay for the Quantitative Determination of Ovarian Cancer Antigen in Human Serum

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Enzyme Linked Immunosorbent Assay for the Quantitative Determination of Alpha Feto Protein in Human Serum

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Fluorescence Immunoassay for Quantitative detection of Prostate Specific Antigen in Human Serum/Plasma

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Chemiluminescence Assay for the Quantitative Determination of Ovarian Cancer Antigen in Human Serum

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Enzyme Linked Immunosorbent Assay for the Quantitative Determination of Breast Cancer Antigen in Human Serum

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C

Fluorescence Immunoassay for Quantitative detection of Cardiac Troponin I in Human Serum/Plasma

Brand: CA 15-3

ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED

Class C